Catenin-Beta Monoclonal Antibody(4F2)

The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants.

Introducing the Catenin-Beta Monoclonal Antibody (4F2), a cutting-edge product designed to revolutionize the field of molecular biology. This highly specific antibody is meticulously crafted to target and detect the catenin-beta protein, a crucial component in cellular adhesion and signaling pathways.

The Catenin-Beta Monoclonal Antibody (4F2) boasts exceptional affinity and selectivity, ensuring accurate and reliable results in various experimental settings. Its superior performance is attributed to the advanced hybridoma technology employed during its development, guaranteeing a high degree of purity and consistency.

With its unrivaled sensitivity, this antibody enables researchers to delve into the intricate mechanisms underlying cellular processes, such as cell adhesion, migration, and differentiation. Its exceptional specificity allows for precise identification and localization of catenin-beta, facilitating comprehensive investigations into its functional roles and interactions within the cell.

The Catenin-Beta Monoclonal Antibody (4F2) is compatible with a wide range of applications, including immunohistochemistry, immunofluorescence, and Western blotting. Its versatility empowers scientists to explore diverse biological systems and unravel the complexities of catenin-beta's involvement in various physiological and pathological conditions.

Furthermore, this antibody is meticulously validated through rigorous quality control measures, ensuring optimal performance and reproducibility. Its long shelf life and stability guarantee consistent results, making it an indispensable tool for both basic research and clinical applications.

In summary, the Catenin-Beta Monoclonal Antibody (4F2) represents a breakthrough in molecular biology research, offering unparalleled specificity, sensitivity, and versatility. With its exceptional performance and reliability, this antibody is poised to drive scientific advancements and contribute to a deeper understanding of cellular processes.